INHIBITION OF P38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS

Patent №

US 7,517,880

Granted

2009-04-14

Filed 2002

Owner

BAYER CORPORATION

+2 more

Lab

AI components

1

evo

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

10060396

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.

Evolutionary computationA61K 31/17A61K 31/341A61K 31/381A61K 31/4035A61K 31/44A61K 31/5375A61P 1/00A61P 11/00+5 more

AI classification

Evolutionary computation0.51
Natural language0.01
Machine learning0.00
Speech0.00
AI hardware0.00
Vision0.00
Planning0.00
Knowledge representation0.00

Ownership

BAYER CORPORATION

assignment · 128510609

BAYER PHARMACEUTICALS CORPORATION

assignment · 141250545

BAYER HEALTHCARE LLC

assignment · 218930336

Assignors

MILLER, SCOTT, OSTERHOUT, MARTIN, DUMAS, JACQUES, KHIRE, UDAY, LOWINGER, TIMOTHY B., SCOTT, WILLIAM J., SMITH, ROGER A., WOOD, JILL E., GUNN, DAVID E., HATOUM-MOKDAD, HOLIA, RODRIGUEZ, MARTHA, SIBLEY, ROBERT, +3 more

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC